Antibiotic resistance in East Asia: current status, risks, and response strategies
The Journal of Infection in Developing Countries · 2026
DOI: 10.3855/jidc.21637 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infection in Developing Countries, 2026. Verfasst von Jiuding Zhang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Hanzhong City Center for Disease Control and Prevention, Shaanxi, China. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Drug Resistance, Bacterial. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
This study investigates the current status and regional disparities of resistance to novel antibiotics in East Asia, exploring links to socioeconomic factors and identifying high-risk resistance determinants. Methodology: Metagenomic sequencing was performed on 1024 human fecal samples (25 local, 999 public) from 12 regions across China and Japan. Antibiotic resistance genes (ARGs) were identified by aligning sequences against a comprehensive antibiotic resistance database, focusing on 8 novel antibiotic classes. The relationship between regional per capita GDP and resistance rates for clinically relevant novel antibiotics was statistically analyzed.
Results
Significant regional variation in resistance rates was observed for clinically used novel antibiotics (aminocoumarins, glycylcyclines, oxacephems, oxazolidinones, pleuromutilins). A significant inverse correlation was found between per capita GDP and resistance rates for aminocoumarins, glycylcyclines, and oxacephems, particularly pronounced within inland regions. Oxacephem resistance was alarmingly high (> 55% in all regions, > 90% in some). Oxazolidinone resistance remained low (< 28%). Pleuromutilin resistance showed a strong negative GDP correlation only inland. Analysis revealed 24 high-frequency ARGs (5 exceeding 45% coverage: CfxA, IsaB, MexB, abeS, IsaE). Minimal shared resistance determinants existed among novel antibiotic classes, except between oxazolidinones and pleuromutilins.
Conclusions
Resistance to novel antibiotics in East Asia exhibits significant regional heterogeneity, strongly influenced by local economic development levels. Resistance rates for specific agents (e.g., oxacephems) critically limit their clinical utility, necessitating mandatory susceptibility testing. High-frequency ARGs linked to traditional antibiotic misuse pose cross-resistance risks. Surveillance and stewardship strategies must be regionally tailored, prioritizing vulnerable areas and tracking critical resistance loci for novel agents.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hanzhong City Center for Disease Control and Prevention, Shaanxi, China.
- Gansu Medical College, Gansu, China.
- Wuwei Vocational and Technical University, Gansu, China.
- Longdong University, Gansu, China.
- The Third Affiliated Hospital of Gansu University of Chinese Medicine, Gansu, China.
- Gansu Academy of Sciences, Gansu, China.
Zitieren
APA
Zhang, J., Fan, J., Li, D., Yang, C., Cheng, Z., Cheng, Z., Qu, H., Li, G., Yuan, N., Song, T., Zhou, K., Zhao, Y., & Wang, X. (2026). Antibiotic resistance in East Asia: current status, risks, and response strategies. The Journal of Infection in Developing Countries. https://doi.org/10.3855/jidc.21637
Vancouver
Zhang J, Fan J, Li D, Yang C, Cheng Z, Cheng Z, et al. Antibiotic resistance in East Asia: current status, risks, and response strategies. The Journal of Infection in Developing Countries. 2026. doi:10.3855/jidc.21637
BibTeX
@article{Zhang2026,
author = {Zhang, Jiuding and Fan, Jinghua and Li, Dongfang and Yang, Caiping and Cheng, Ziqi and Cheng, Zihan and Qu, Hongmei and Li, Guoliang and Yuan, Ning and Song, Taixian and Zhou, Kaichun and Zhao, Yumin and Wang, Xingsheng},
title = {Antibiotic resistance in East Asia: current status, risks, and response strategies},
journal = {The Journal of Infection in Developing Countries},
year = {2026},
doi = {10.3855/jidc.21637}
}
EUVIMED